An “extraordinary” brain network discovery shows that Parkinson’s disease may not be a movement disorder after all ...
A study published in Molecular Psychiatry reveals a path of cause-effect molecular events that can lead to Alzheimer's ...
Mass General Brigham researchers are betting that the next big leap in brain medicine will come from teaching artificial ...
Some forms of dementia may not be confined to the central nervous system; they may not even begin in the brain.
Origami is collaborating with Ipsen to develop molecules designed to remove or correct abnormal proteins in neurodegenerative diseases.
Hemoglobin could hold the key to new treatments for neurodegenerative diseases. The protein found in red blood cells that transports oxygen in the body could play a potentially game-changing—and ...
A new Alzheimer's treatment side effect that results in brain swelling may have an upside, according to a new study from Houston Methodist Research Institute. The research finds that beta amyloid—a ...
Morning Overview on MSN
1 in 3 dementia cases tied to a disease that starts outside the brain
Roughly 37% of new dementia cases in older Americans may be linked to diseases that begin outside the brain, according to a ...
A new study study finds that brain swelling (ARIA-E) from Alzheimer's drugs identifies the regions where amyloid plaques are being cleared most effectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results